EDGAR Filing Documents for 0001209191-13-045762

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001209191-13-045762

Filing Date

2013-09-26

Accepted

2013-09-26 16:16:09

Documents

Period of Report

2013-09-24

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 4 SUBMISSION	doc4.html	4
1	FORM 4 SUBMISSION	doc4.xml	4	15202
	Complete submission text file	0001209191-13-045762.txt		16774

Mailing Address 86 MORRIS AVENUE SUMMIT NJ 07901

Business Address 86 MORRIS AVENUE SUMMIT NJ 07901 (908)673-9000

CELGENE CORP /DE/ (Reporting) CIK: 0000816284 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-36065 | Film No.: 131116991
SIC: 2834 Pharmaceutical Preparations

Mailing Address 128 SYDNEY STREET CAMBRIDGE MA 02139

Business Address 128 SYDNEY STREET CAMBRIDGE MA 02139 617-649-9200

ACCELERON PHARMA INC (Issuer) CIK: 0001280600 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)